<i>MAX</i> Mutations Cause Hereditary and Sporadic Pheochromocytoma and ParagangliomaNelly Burnichon, Elisa Taschin, Nasséra Abermil et al.|Clinical Cancer Research|2012Cited by 330
Consensus Statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomasPatricia L. M. Dahia, Rodrigo A. Toledo, Nelly Burnichon et al.|Nature Reviews Endocrinology|2016Cited by 267
Spectrum and Prevalence of <i>FP/TMEM127</i> Gene Mutations in Pheochromocytomas and ParagangliomasLi Yao, Patricia L. M. Dahia, Francesca Schiavi et al.|JAMA|2010Cited by 200
Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosisIñaki Comino‐Méndez, Alberto Cascón, Aguirre A. de Cubas et al.|Human Molecular Genetics|2013Cited by 168
Metabolome-guided genomics to identify pathogenic variants in isocitrate dehydrogenase, fumarate hydratase, and succinate dehydrogenase genes in pheochromocytoma and paragangliomaSusan Richter, Barbara Klink, Laura Gieldon et al.|Genetics in Medicine|2018Cited by 100